Latest News - Psoriasis

Thursday, April 27, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com

ASA Honors Researchers At Annual Meeting of the Society for Investigative Dermatology

Richard Edelson, MD Chair and Professor, Department of Dermatology, Yale School of Medicine, took home the David Martin Carter Mentor Award from the American Skin Association at the Annual M…

Read the full story

Friday, April 21, 2017 | PracticalDermatology.com, Product Launches and Updates, Valeant NJ

Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ as Lowest Priced Injectable Biologic For Psoriasis

Following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), Valeant Pharmaceuticals International, Inc. has decided to list SILIQ (brodalumab) injection at $3,500 per mon…

Read the full story

Wednesday, April 19, 2017 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Atopic Derm, Atopic Dermatitis , Eczema

Topical Cannabinoids May Soothe Itchy Skin

Cannabinoids contain anti-inflammatory properties that may make them useful in the treatment of a wide-range of skin diseases including  eczema, psoriasis, atopic and contact dermatitis, accordin…

Read the full story

Thursday, March 30, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, AbbVie

FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to Humira Prescribing Information

The FDA approved the inclusion of moderate to severe fingernail psoriasis data in AbbVie's Humira (adalimumab) prescribing information for patients with moderate to severe chronic plaque psoriasis…

Read the full story

Friday, March 24, 2017 | PracticalDermatology.com, Research and Publications

Study: Severe Psoriasis More Common in Men

Severe psoriasis predominantly affects men, according to a new study in the American Journal of Clinical Dermatology. In the study of 5,438 Swedish psoriasis patients, women had significantly …

Read the full story

Monday, March 06, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Novartis, Psoriasis

Sandoz Proposed Biosimilar Shows Equivalent Efficacy to Humira

Sandoz’s proposed biosimilar adalimumab (GP2017) shows equivalent efficacy to reference medicine, according to data presented at the American Academy of Dermatology (AAD) in Orlando, Florida. …

Read the full story

Thursday, March 02, 2017 | Phase 3/4 Trials, PracticalDermatology.com, American Academy of Dermatology, Sun Pharmaceutical Industries Ltd

Sun Pharma to Present Data from Tildrakizumab Clinical Development Program at 2017 AAD Meeting

Sun Pharmaceutical Industries Ltd will present several new analyses from Phase-1 and the pivotal Phase-3 clinical trials (reSURFACE 1 and 2) of tildrakizumab, an investigational IL-23p19 inhibitor bei…

Read the full story

Wednesday, March 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Skin Diseases Remain Major Cause of Disability

Skin diseases are the fourth leading cause of disability worldwide, according to the Global Burden of Disease 2013 Study which appears online in JAMA Dermatology. For the study, researchers estimat…

Read the full story

Wednesday, March 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, American Academy of Dermatology

AAD Launches SkinSerious Campaign

The American Academy of Dermatology is launching a new campaign to raise awareness of the breadth of serious skin diseases as well as the critical role dermatologists play in an era of team-based heal…

Read the full story

Monday, February 27, 2017 | PracticalDermatology.com, Research and Publications

Depression, Psoriasis And Risk Of Psoriatic Arthritis: What’s the Connection?

Psoriasis patients who develop depression are at a 37 percent greater risk of developing psoriatic arthritis, compared with psoriasis patients who did not develop depression, according to a new study …

Read the full story

Thursday, February 16, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Valeant NJ

FDA Approves Valeant's SILIQ For Moderate-To-Severe Plaque Psoriasis

The FDA has approved the Biologics License Application (BLA) for Valeant Pharmaceutical's SILIQ (brodalumab) injection, for subcutaneous use, a monoclonal antibody that targets the IL-17 receptor …

Read the full story

Wednesday, February 08, 2017 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Study Finds Increased Incidence of SCC Among Patients Treated with Biologics for Psoriasis

A recent study published in the Journal of the American Academy of Dermatology sought to estimate the overall malignancy rate (excluding non-melanoma skin cancere [NMSC]) and NMSC rate among 5,889 pat…

Read the full story

Monday, January 30, 2017 | PracticalDermatology.com, PracticalDermatology.com

Dr. David Norris Named New ASA President

David Norris, MD, Chairman of the Department of Dermatology at the University of Colorado School of Medicine, is the new President of American Skin Association (ASA). …

Read the full story

Thursday, January 26, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Melanoma

Congratulations: American Skin Association Announces 2017 Research Scholar Awards and Research Grants

And the winners are … The American Skin Association (ASA) research scholar awards and research grants are: ASA Carson Research Scholar Award in Psoriasis Cory L. Simpson, MD, PhD Un…

Read the full story

Wednesday, January 25, 2017 | PracticalDermatology.com, PracticalDermatology.com

New Plush Wonder Duck Toy Benefits Children's Skin Disease Foundation and Camp Wonder

A plush version of Camp Wonder’s mascot, Wonder Duck, is now available for purchase, with 100% of the proceeds going to the Children's Skin Disease Foundation. Camp Wonder is a summe…

Read the full story
Load More